Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 617 entries
Sorted by: Best Match Show Resources per page
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T.
PMID: 28927133
Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.

Rebiopsy is considered an option for specific types of cancer, such as breast, non-small cell lung, and prostate cancer, in clinical trials and in practice. The benefit of rebiopsy comes from the selection of a new treatment strategy based...

Cite
Kawasaki K, Hamamoto Y, Suzuki T, et al. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017;14(3):3697-3700doi: 10.3892/ol.2017.6601.
Kawasaki, K., Hamamoto, Y., Suzuki, T., Hirata, K., Sukawa, Y., Kasuga, A., Hayashi, Y., Takaishi, H., Kameyama, K., & Kanai, T. (2017). Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncology letters, 14(3), 3697-3700. https://doi.org/10.3892/ol.2017.6601
Kawasaki, Kenta, et al. "Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report." Oncology letters vol. 14,3 (2017): 3697-3700. doi: https://doi.org/10.3892/ol.2017.6601
Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18. PMID: 28927133; PMCID: PMC5587936.
Copy Download .nbib Format: NLM
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation.

Acute medicine & surgery

Kashiura M, Tateishi K, Yokoyama T, Jujo M, Tanabe T, Sugiyama K, Akashi A, Hamabe Y.
PMID: 29123847
Acute Med Surg. 2016 Aug 01;4(1):119-122. doi: 10.1002/ams2.234. eCollection 2017 Jan.

CASE: Two cases of cardiogenic unilateral pulmonary edema are reported. Both patients presented to the emergency department with dyspnea, and chest radiography revealed unilateral infiltration, which mimics pulmonary disease. However, the patients were diagnosed with cardiogenic pulmonary edema, because...

Cite
Kashiura M, Tateishi K, Yokoyama T, et al. Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation. Acute Med Surg. 2016;4(1):119-122doi: 10.1002/ams2.234.
Kashiura, M., Tateishi, K., Yokoyama, T., Jujo, M., Tanabe, T., Sugiyama, K., Akashi, A., & Hamabe, Y. (2017). Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation. Acute medicine & surgery, 4(1), 119-122. https://doi.org/10.1002/ams2.234
Kashiura, Masahiro, et al. "Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation." Acute medicine & surgery vol. 4,1 (2017): 119-122. doi: https://doi.org/10.1002/ams2.234
Kashiura M, Tateishi K, Yokoyama T, Jujo M, Tanabe T, Sugiyama K, Akashi A, Hamabe Y. Unilateral cardiogenic pulmonary edema associated with acute mitral regurgitation. Acute Med Surg. 2016 Aug 01;4(1):119-122. doi: 10.1002/ams2.234. eCollection 2017 Jan. PMID: 29123847; PMCID: PMC5667298.
Copy Download .nbib Format: NLM
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review.

OncoTargets and therapy

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
PMID: 27051299
Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016.

Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts for

Cite
Oba T, Ono M, Iesato A, et al. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016;9:1641-6doi: 10.2147/OTT.S88726.
Oba, T., Ono, M., Iesato, A., Hanamura, T., Watanabe, T., Ito, T., Kanai, T., Maeno, K., Ito, K., Tateishi, A., Yoshizawa, A., & Takayama, F. (2016). Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. OncoTargets and therapy, 91641-6. https://doi.org/10.2147/OTT.S88726
Oba, Takaaki, et al. "Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review." OncoTargets and therapy vol. 9 (2016): 1641-6. doi: https://doi.org/10.2147/OTT.S88726
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016. PMID: 27051299; PMCID: PMC4807953.
Copy Download .nbib Format: NLM
Septic shock due to infected giant venous malformation complicated by massive bleeding.

Acute medicine & surgery

Tomita K, Watanabe E, Sadahiro T, Tateishi Y, Shinozaki K, Rikihisa N, Oda S.
PMID: 29123799
Acute Med Surg. 2015 Dec 22;3(3):279-282. doi: 10.1002/ams2.175. eCollection 2016 Jul.

CASE: A 19-year-old man with a hemangioma that extended from the left arm to the axillary region had deteriorated due to shock, and no improvement was observed after fluid resuscitation. His status on arrival led to complications of hemorrhagic...

Cite
Tomita K, Watanabe E, Sadahiro T, et al. Septic shock due to infected giant venous malformation complicated by massive bleeding. Acute Med Surg. 2015;3(3):279-282doi: 10.1002/ams2.175.
Tomita, K., Watanabe, E., Sadahiro, T., Tateishi, Y., Shinozaki, K., Rikihisa, N., & Oda, S. (2016). Septic shock due to infected giant venous malformation complicated by massive bleeding. Acute medicine & surgery, 3(3), 279-282. https://doi.org/10.1002/ams2.175
Tomita, Keisuke, et al. "Septic shock due to infected giant venous malformation complicated by massive bleeding." Acute medicine & surgery vol. 3,3 (2016): 279-282. doi: https://doi.org/10.1002/ams2.175
Tomita K, Watanabe E, Sadahiro T, Tateishi Y, Shinozaki K, Rikihisa N, Oda S. Septic shock due to infected giant venous malformation complicated by massive bleeding. Acute Med Surg. 2015 Dec 22;3(3):279-282. doi: 10.1002/ams2.175. eCollection 2016 Jul. PMID: 29123799; PMCID: PMC5667241.
Copy Download .nbib Format: NLM
Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy.

Modern rheumatology

Takeishi M, Mimori A, Suzuki T.
PMID: 24387020
Mod Rheumatol. 2001 Mar;11(1):47-51. doi: 10.3109/s101650170043.

Abstract This work was undertaken to evaluate clinical and immunological features in patients with systemic lupus erythematosus (SLE) complicated by Jaccoud's arthropathy. Patients diagnosed with SLE between 1985 and 1999, and who met the criteria of Villiaumey et al.,...

Cite
Takeishi M, Mimori A, Suzuki T. Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy. Mod Rheumatol. 2001;11(1):47-51doi: 10.3109/s101650170043.
Takeishi, M., Mimori, A., & Suzuki, T. (2001). Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy. Modern rheumatology, 11(1), 47-51. https://doi.org/10.3109/s101650170043
Takeishi, M, et al. "Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy." Modern rheumatology vol. 11,1 (2001): 47-51. doi: https://doi.org/10.3109/s101650170043
Takeishi M, Mimori A, Suzuki T. Clinical and immunological features of systemic lupus erythematosus complicated by Jaccoud's arthropathy. Mod Rheumatol. 2001 Mar;11(1):47-51. doi: 10.3109/s101650170043. PMID: 24387020.
Copy Download .nbib Format: NLM
Synthesis of monolayer platinum nanosheets.

Chemical communications (Cambridge, England)

Funatsu A, Tateishi H, Hatakeyama K, Fukunaga Y, Taniguchi T, Koinuma M, Matsuura H, Matsumoto Y.
PMID: 24947470
Chem Commun (Camb). 2014 Aug 11;50(62):8503-6. doi: 10.1039/c4cc02527j.

Platinum (Pt) nanosheets were developed by exfoliating layered platinum oxide. Moreover, we succeeded in synthesizing monolayer Pt nanosheets for the first time by adjusting the conditions for reduction. Monolayer Pt nanosheets were highly active in oxygen reduction reaction.

Cite
Funatsu A, Tateishi H, Hatakeyama K, et al. Synthesis of monolayer platinum nanosheets. Chem Commun (Camb). 2014;50(62):8503-6doi: 10.1039/c4cc02527j.
Funatsu, A., Tateishi, H., Hatakeyama, K., Fukunaga, Y., Taniguchi, T., Koinuma, M., Matsuura, H., & Matsumoto, Y. (2014). Synthesis of monolayer platinum nanosheets. Chemical communications (Cambridge, England), 50(62), 8503-6. https://doi.org/10.1039/c4cc02527j
Funatsu, A, et al. "Synthesis of monolayer platinum nanosheets." Chemical communications (Cambridge, England) vol. 50,62 (2014): 8503-6. doi: https://doi.org/10.1039/c4cc02527j
Funatsu A, Tateishi H, Hatakeyama K, Fukunaga Y, Taniguchi T, Koinuma M, Matsuura H, Matsumoto Y. Synthesis of monolayer platinum nanosheets. Chem Commun (Camb). 2014 Aug 11;50(62):8503-6. doi: 10.1039/c4cc02527j. PMID: 24947470.
Copy Download .nbib Format: NLM
Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C.

NDT plus

Mimura I, Ishibashi Y, Tateishi R, Kaname S, Fujita T.
PMID: 25983890
NDT Plus. 2008 Aug;1(4):233-5. doi: 10.1093/ndtplus/sfn069. Epub 2008 Jun 05.

BACKGROUND: Although pegylated interferon (PEG-IFN) is now the standard treatment for chronic hepatitis C, there are few reports targeting dialysis patients and treatment protocol for hepatitis C virus (HCV) infection has not been determined, particularly in patients on peritoneal...

Cite
Mimura I, Ishibashi Y, Tateishi R, et al. Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C. NDT Plus. 2008;1(4):233-5doi: 10.1093/ndtplus/sfn069.
Mimura, I., Ishibashi, Y., Tateishi, R., Kaname, S., & Fujita, T. (2008). Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C. NDT plus, 1(4), 233-5. https://doi.org/10.1093/ndtplus/sfn069
Mimura, Imari, et al. "Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C." NDT plus vol. 1,4 (2008): 233-5. doi: https://doi.org/10.1093/ndtplus/sfn069
Mimura I, Ishibashi Y, Tateishi R, Kaname S, Fujita T. Pegylated interferon alpha-2a monotherapy in a peritoneal dialysis patient with chronic hepatitis C. NDT Plus. 2008 Aug;1(4):233-5. doi: 10.1093/ndtplus/sfn069. Epub 2008 Jun 05. PMID: 25983890; PMCID: PMC4421225.
Copy Download .nbib Format: NLM
Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study.

World journal of radiology

Fujioka T, Kubota K, Toriihara A, Machida Y, Okazawa K, Nakagawa T, Saida Y, Tateishi U.
PMID: 27648168
World J Radiol. 2016 Aug 28;8(8):743-9. doi: 10.4329/wjr.v8.i8.743.

AIM: To clarify clinicopathological features of ductal carcinoma in situ (DCIS) visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT).METHODS: This study retrospectively reviewed 52 consecutive tumors in 50 patients with pathologically proven pure DCIS who underwent [F-18] FDG-PET/CT before...

Cite
Fujioka T, Kubota K, Toriihara A, et al. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study. World J Radiol. 2016;8(8):743-9doi: 10.4329/wjr.v8.i8.743.
Fujioka, T., Kubota, K., Toriihara, A., Machida, Y., Okazawa, K., Nakagawa, T., Saida, Y., & Tateishi, U. (2016). Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study. World journal of radiology, 8(8), 743-9. https://doi.org/10.4329/wjr.v8.i8.743
Fujioka, Tomoyuki, et al. "Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study." World journal of radiology vol. 8,8 (2016): 743-9. doi: https://doi.org/10.4329/wjr.v8.i8.743
Fujioka T, Kubota K, Toriihara A, Machida Y, Okazawa K, Nakagawa T, Saida Y, Tateishi U. Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective study. World J Radiol. 2016 Aug 28;8(8):743-9. doi: 10.4329/wjr.v8.i8.743. PMID: 27648168; PMCID: PMC5002505.
Copy Download .nbib Format: NLM
A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT.

Respiratory medicine case reports

Kato A, Yamamoto H, Ikeda M, Tateishi K, Ushiki A, Yasuo M, Kawakami S, Asaka S, Oguchi K, Hanaoka M.
PMID: 27489760
Respir Med Case Rep. 2016 Jul 07;19:49-52. doi: 10.1016/j.rmcr.2016.07.004. eCollection 2016.

We encountered a middle-aged afebrile immunocompetent woman with a slight cough. Positron emission tomography (PET)/computed tomography (CT) revealed a broad left upper-lobe consolidation without cavity lesions, small nodules, or bronchiectasis showing a positive fluorodeoxyglucose (FDG) uptake with a maximum...

Cite
Kato A, Yamamoto H, Ikeda M, et al. A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT. Respir Med Case Rep. 2016;19:49-52doi: 10.1016/j.rmcr.2016.07.004.
Kato, A., Yamamoto, H., Ikeda, M., Tateishi, K., Ushiki, A., Yasuo, M., Kawakami, S., Asaka, S., Oguchi, K., & Hanaoka, M. (2016). A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT. Respiratory medicine case reports, 1949-52. https://doi.org/10.1016/j.rmcr.2016.07.004
Kato, Akane, et al. "A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT." Respiratory medicine case reports vol. 19 (2016): 49-52. doi: https://doi.org/10.1016/j.rmcr.2016.07.004
Kato A, Yamamoto H, Ikeda M, Tateishi K, Ushiki A, Yasuo M, Kawakami S, Asaka S, Oguchi K, Hanaoka M. A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT. Respir Med Case Rep. 2016 Jul 07;19:49-52. doi: 10.1016/j.rmcr.2016.07.004. eCollection 2016. PMID: 27489760; PMCID: PMC4961796.
Copy Download .nbib Format: NLM
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography.

Hepatology research : the official journal of the Japan Society of Hepatology

Mikami S, Tateishi R, Hagiwara S, Sato M, Minami T, Uchino K, Enooku K, Sato T, Nakagawa H, Masuzaki R, Asaoka Y, Kondo Y, Shiina S, Ikeda H, Omata M, Yoshida H, Koike K.
PMID: 24861870
Hepatol Res. 2015 Apr;45(4):415-22. doi: 10.1111/hepr.12365. Epub 2014 Jun 19.

AIM: The objectives of this study was to evaluate the utility of tumor markers in hepatocellular carcinoma (HCC) surveillance based on the reliability of ultrasonography.METHODS: We analyzed 313 patients with HCC detected through a surveillance program using ultrasonography combined...

Cite
Mikami S, Tateishi R, Hagiwara S, et al. Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography. Hepatol Res. 2014;45(4):415-22doi: 10.1111/hepr.12365.
Mikami, S., Tateishi, R., Hagiwara, S., Sato, M., Minami, T., Uchino, K., Enooku, K., Sato, T., Nakagawa, H., Masuzaki, R., Asaoka, Y., Kondo, Y., Shiina, S., Ikeda, H., Omata, M., Yoshida, H., & Koike, K. (2015). Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography. Hepatology research : the official journal of the Japan Society of Hepatology, 45(4), 415-22. https://doi.org/10.1111/hepr.12365
Mikami, Shintaro, et al. "Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,4 (2015): 415-22. doi: https://doi.org/10.1111/hepr.12365
Mikami S, Tateishi R, Hagiwara S, Sato M, Minami T, Uchino K, Enooku K, Sato T, Nakagawa H, Masuzaki R, Asaoka Y, Kondo Y, Shiina S, Ikeda H, Omata M, Yoshida H, Koike K. Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography. Hepatol Res. 2015 Apr;45(4):415-22. doi: 10.1111/hepr.12365. Epub 2014 Jun 19. PMID: 24861870.
Copy Download .nbib Format: NLM
Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke.

Interventional neurology

Tateishi Y, Wisco D, Aoki J, George P, Katzan I, Toth G, Hui F, Hussain MS, Uchino K.
PMID: 25999992
Interv Neurol. 2015 Jan;3(1):48-55. doi: 10.1159/000369835.

OBJECTIVE: This study investigated whether large ischemic lesions in the deep white matter (DWM) on pretreatment diffusion-weighted MRI (DWI) predict futile recanalization.METHODS: Consecutive acute stroke patients with anterior circulation ischemia who underwent successful arterial recanalization with thrombolysis in cerebral...

Cite
Tateishi Y, Wisco D, Aoki J, et al. Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke. Interv Neurol. 2015;3(1):48-55doi: 10.1159/000369835.
Tateishi, Y., Wisco, D., Aoki, J., George, P., Katzan, I., Toth, G., Hui, F., Hussain, M. S., & Uchino, K. (2015). Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke. Interventional neurology, 3(1), 48-55. https://doi.org/10.1159/000369835
Tateishi, Yohei, et al. "Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke." Interventional neurology vol. 3,1 (2015): 48-55. doi: https://doi.org/10.1159/000369835
Tateishi Y, Wisco D, Aoki J, George P, Katzan I, Toth G, Hui F, Hussain MS, Uchino K. Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke. Interv Neurol. 2015 Jan;3(1):48-55. doi: 10.1159/000369835. PMID: 25999992; PMCID: PMC4436528.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 617 entries